Showing results (511-520 of 763) with videos related to
Sort By:
Pageof 77
International Journal of Molecular Sciences|May 13, 2023
Immunophenotypic Alterations in Adult Patients with Steroid-Dependent and Frequently Relapsing Nephrotic SyndromeFederica Casiraghi, Marta Todeschini, Manuel Alfredo Podestà, et al.Journal of Ophthalmology|July 15, 2010
Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trialPiero Ruggenenti, Ilian Iliev, Marco Filipponi, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 13, 2017
Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysisChristophe M Legendre, Josep M Campistol, Thorsten Feldkamp, et al.Thrombosis and Haemostasis|February 5, 2009
Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodiesElena Bresin, Sara Gastoldi, Erica Daina, et al.American Journal of Physiology. Renal Physiology|September 7, 2012
Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathyCarla Zoja, Pablo Bautista Garcia, Cinzia Rota, et al.Stem Cell Research|June 15, 2016
Generation of functional podocytes from human induced pluripotent stem cellsOsele Ciampi, Roberto Iacone, Lorena Longaretti, et al.Clinical Journal of the American Society of Nephrology : CJASN|November 22, 2022
Estimated Lifetime Benefit of Combined RAAS and SGLT2 Inhibitor Therapy in Patients with Albuminuric CKD without DiabetesPriya Vart, Muthiah Vaduganathan, Niels Jongs, et al.Acta Diabetologica|October 14, 2021
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trialFabiola Carrara, Piero Ruggenenti, Annalisa Perna, et al.Kidney International|August 8, 2002
Shiga toxin-2 triggers endothelial leukocyte adhesion and transmigration via NF-kappaB dependent up-regulation of IL-8 and MCP-1Carla Zoja, Stefania Angioletti, Roberta Donadelli, et al.JCI Insight|March 13, 2020
C3a receptor blockade protects podocytes from injury in diabetic nephropathyMarina Morigi, Luca Perico, Daniela Corna, et al.Pageof 77